Autopsy report · NCT01666275
The Metabolomics of Anaphylaxis
Cause of deathSlow enrollment
“We are closing the study because of lack of enrollment.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Patients With AERD Undergoing Aspirin Desensitization
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Adipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae
“Study closed due to lack of patient enrollment.” - A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer
“Study closed to enrollment due to low accrual.” - Salvage Cryotherapy in Recurrent Prostate Cancer
“Study was ended due to low enrollment” - Hand Injected Ventriculography vs. Power Injected Left Ventriculography
“Study was stopped due to low enrollment.” - Impact of Feeding on Pro-Inflammatory Cytokine Response in Neonates Receiving a RBC Transfusion
“Study is being closed due to insufficient patient population for enrollment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.